达里奥·阿莫代伊在信任争议中为Anthropic的AI监管立场辩护
TECH

达里奥·阿莫代伊在信任争议中为Anthropic的AI监管立场辩护

50+
Signals

战略概览

  • 01.
    Anthropic首席执行官达里奥·阿莫代伊在X平台上公开回应投资者加文·贝克尔,称AI行业的反弹是一场信任危机,而非源于他本人的风险警告。
  • 02.
    阿莫代伊拒绝将AI政策视为监管导致权力集中与无监管广泛分布之间的二元选择,他认为前沿AI由于规模经济的结构性原因本身就容易导致权力集中,而仅靠开放权重无法抵消这一点,因为计算资源的获取仍然高度集中。
  • 03.
    阿莫代伊指出,Anthropic参与设计的监管提案(包括加州SB53法案)有意让前沿AI公司处于不利地位,同时惠及小型竞争者,SB53法案将年收入低于5亿美元的公司排除在更严格义务之外。
  • 04.
    阿莫代伊表示支持建立类似美国金融业监管局(FINRA)的独立AI监督机构,并对前沿模型实施部署前测试,称这与六个月前整个行业普遍呼吁废除州级监管相比,是一次有意义的转变。
  • 05.
    阿莫代伊表示,只有切实的成果,尤其是治愈癌症等疾病,才能恢复公众对AI的信任,而不是靠言辞或营销。
  • 06.
    阿莫代伊承认,对AI公司(包括Anthropic)最有力的批评是,它们尚未兑现造福世界的重大承诺。
  • 07.
    阿莫代伊否认自己的公开信息传递过分负面,称其在风险与收益之间大致平衡,并引用他的文章《仁慈的机器》作为乐观立场的佐证。

深度分析

监管捕获论点,逐条剖析

阿莫代伊的核心辩护是结构性的:SB53法案规定,年总收入低于5亿美元的公司可豁免其对大型开发者的强化义务[3],并要求在15天内向州政府报告关键安全事件[4]。他称这一设计旨在使Anthropic自身这样的前沿实验室处于不利地位,同时保护小型竞争者,并将建立类似FINRA的监督机构及部署前测试的更广泛转向,描述为与六个月前行业普遍要求彻底废除州监管相比的重大转变[3]。批评者则反向解读相同的机制。《华盛顿观察家》撰稿人埃里克·米勒认为,阿莫代伊所描述的合规负担对小型竞争者而言遥不可及,直言不讳地指出,十人初创公司根本无法满足[5]。白宫AI与加密事务主管大卫·萨克斯走得更远,称Anthropic的倡导是一种基于制造恐惧的复杂监管捕获策略[5]。双方争议的焦点并非SB53文本本身——两方都引用相同的5亿美元门槛和15天期限——而是围绕门槛和测试构建的合规制度一旦建立,最终会惠及谁。

这并非阿莫代伊的新立场——近几个月来,他在其他场合也提出过类似观点。在《60分钟》节目中,面对其安全叙事只是‘安全表演’的指控,他反驳称Anthropic的主张是可验证的,而非品牌包装,并提出了‘压缩的21世纪’理论,即AI有望治愈大多数癌症并帮助预防阿尔茨海默病。在与Dwarkesh的另一段访谈中,他为自己反对联邦暂停各州AI立法的立场辩护,区分了他所称的‘愚蠢’的田纳西法案与更广泛原则:即没有联邦兜底的全面禁令将无法应对真实风险,这一区分与上述SB53论点一致:他所捍卫的并非监管本身,而是‘设计得当’的监管。

一场阿莫代伊称非其所致的信任危机

阿莫代伊对贝克尔的核心反驳是一种重新定义:AI行业的反弹并非对其个人警告的反应,而是对企业和政府以及整个科技行业长期不信任的症状,他认为这种不信任早于且远超他个人的言论[1]。他也否认其信息传递偏向负面,称其在风险与收益之间大致平衡,并指出其文章《仁慈的机器》证明了其乐观立场的存在[1]。他唯一让步之处颇具深意:他承认对AI公司(包括Anthropic)最准确的批评是,它们尚未兑现对公众的重大承诺[6]。这一让步至关重要,因为它构成了他整个信任论点的基础——如果行业的信誉问题本质上是承诺未兑现,而非对风险的坦率表达,那么解决方案就不是软化信息,而是交付成果。这种框架使他既能承认交付不足的责任,又能拒绝为引发反弹负责,这也正是引发最强烈反对的关键所在。

治愈癌症或一败涂地:阿莫代伊唯一接受的证明

在主张言辞无法重建信任后,阿莫代伊将自己的信誉押在一个单一成果上:‘真正有效的是实际治愈癌症’[2]。他此前曾预测,AI有望在五到十年内帮助治愈大多数疾病,包括癌症[7],将一个长期存在的愿景性口号转化为一个可验证、有明确时间表的个人承诺。这一说法传播甚广,在三个不同子版块的帖子中成为标题:r/technology的版本‘AI赢得公众支持的方式就是真正治愈癌症’获得了约12,000个赞和2,300条评论,远超其他讨论;而r/LocalLLaMA关于其更广泛政策辩护的帖子和r/ArtificialInteligence关于信任危机框架的帖子也获得了较小但活跃的关注。这种传播表明,‘治愈癌症’这一说法,比阿莫代伊回应中的任何其他部分,更能穿透至普通受众。

唯一点燃导火索的私营公司

整个事件的源头可追溯至一个被转述的说法:在All-In播客中,加文·贝克尔援引匿名消息源称,阿莫代伊曾表示Anthropic可能最终成为唯一幸存的私营公司。Anthropic研究员肖尔托·道格拉斯迅速驳斥该说法‘完全错误’,强调任何政府都不应允许单一公司积累如此大的影响力,竞争和资本主义才是真正的目标[6]。大卫·萨克斯也加入批评,称该说法本身傲慢,同时借此重申他对该公司监管捕获的独立指控[6]。贝克尔在回应道格拉斯的否认时并未放弃论点,而是重新定义了争议:他感谢道格拉斯澄清事实,但指出许多硅谷严肃人士之所以听信并相信该说法的某种版本,正是因为这与阿莫代伊此前关于权力集中的公开信息一致。在X平台上,一位知名用户在回应阿莫代伊的帖子时称其为‘两面讨巧的大师级操作’,指出他不能一边声称前沿AI结构性地集中权力,一边坚称由其参与设计的规则能遏制这种集中,而非将其锁定在其自身公司周围。

历史背景

Anthropic公开支持加州SB53法案,该法案要求大型前沿AI开发者发布安全框架、在15天内报告关键安全事件、保护举报人,并对违规行为处以处罚。
埃里克·米勒发表评论文章,批评阿莫代伊的监管推动实质上是巩固Anthropic地位的监管捕获,并引用阿莫代伊在参议院听证会上将强大未来AI系统比作可武器化的核材料的证词。
阿莫代伊在X平台上发布长文回应加文·贝克尔,为其AI风险信息传递和监管立场辩护,并称AI行业的反弹本质上是一场信任危机。

关键关系图

关键玩家
主题

达里奥·阿莫代伊在信任争议中为Anthropic的AI监管立场辩护

DA

Dario Amodei

Anthropic CEO; publicly defended his AI-risk messaging and regulatory positions against claims they fuel distrust or amount to regulatory capture; controls Anthropic's public policy stance and company messaging.

GA

Gavin Baker

Investor, CIO of Atreides Management; argued on the All-In podcast and on X that Amodei's AI-risk warnings fueled public backlash against AI, including data-center opposition, and relayed a claim from unnamed sources that Amodei said Anthropic might become the only private company in the world; urged Amodei to be a more positive industry advocate.

SH

Sholto Douglas

Anthropic researcher; publicly and swiftly denied Baker's only private company claim as completely false, arguing government should not let any company have that much influence.

DA

David Sacks

White House AI and crypto czar; has separately accused Anthropic of running a sophisticated regulatory capture strategy based on fear-mongering and blamed the company for state-level AI regulatory frenzy damaging startups; also called the only private company claim hubristic.

DE

Demis Hassabis

Google DeepMind CEO; proposed a FINRA-like independent AI oversight body, which Amodei endorsed as part of his regulatory defense.

事实来源

7 条引用
  1. [1] Anthropic CEO says AI backlash is 'fundamentally a crisis of trust'
  2. [2] Dario Amodei says AI faces a trust crisis over regulation, frontier models and negative views
  3. [3] Anthropic CEO: AI regulation can constrain big firms, help rivals
  4. [4] Anthropic is endorsing SB 53
  5. [5] Anthropic Armageddon: Amodei, AI competition, and regulatory capture
  6. [6] Claim that Anthropic wants to be the only private company in the world draws CEO Dario Amodei to X with clarification
  7. [7] AI could help cure most diseases in 5-10 years: Anthropic CEO

来源文章

Top 5

THE SIGNAL.

Analysts

认为,如果监管设计得当,通过分级门槛和对前沿实验室更严格的测试机制,反而能约束权力集中而非巩固之,而AI结构性地导致权力集中源于规模经济,而非监管本身。

Dario Amodei
Anthropic首席执行官

认为阿莫代伊的监管推动是监管捕获的蓝图,指出其所暗示的合规负担对极小型公司而言无法承受,直言‘十人初创公司无法’满足。

Eric Miller
《华盛顿观察家》专栏作者

认为阿莫代伊的AI风险言论在硅谷严肃人士中广为相信,正是因为它与其本人的公开信息一致,他对肖尔托·道格拉斯表示:‘之所以如此多人相信,是因为它与达里奥的公开信息一致。’

Gavin Baker
Atreides Management首席投资官
The Crowd

1/2 Thanks Gavin for an especially thoughtful exchange. I don't usually spend much time on social media but I wanted to engage here because it really brings out the heart of an important conversation. First, on regulation, I think that “either concentrate it in the hands of a chosen few companies and politicians via regulation or distribute it widely” is a false choice. I know that there's a sort of Silicon Valley shorthand where regulation = regulatory capture = concentration of power, but I've always found this to be an overly simplified picture of the world... Overall my view is that AI is *structurally* a technology that tends to concentrate power, for reasons that have nothing to do with regulation (more to do with the extreme implications of the scaling laws). Open-weights do help some with this but are nowhere near a sufficient solution... I am also supportive of Demis Hassabis' ideas around a FINRA-like entity.

@@DarioAmodei8651

2/2 Second, on the messaging around AI. I do not agree that my messaging has been disproportionately negative... The bulk of [Machines of Loving Grace] is devoted to refuting skepticism of AI's potential in health and biology, and showing why I think it will actually be possible to cure most human disease in ~5-10 years... I do agree that the public has a negative view of AI... I think it is fundamentally a crisis of trust... I don't think that a glitzy marketing campaign with a positive spin... is the way to win back that trust — at this point, saying that AI will cure cancer is more a cliche than it is inspiring... The thing that will work is *actually curing cancer*.

@@DarioAmodei8619

I am doing my best to stop back from this subject as it should be obvious what we are seeing here. However the arrogance that us commoners are too dumb to catch his grift must be addressed. Receipts: Dario Amodei's carefully worded reply is a masterclass in having it both ways. He frames regulation as a nuanced force for decentralization while his actual track record and recent actions scream regulatory capture designed to protect Anthropic's closed, frontier position. The contradictions are not subtle; they are structural... The deeper contradiction is the one he never resolves: he admits scaling laws structurally concentrate power in the hands of those with the most compute and chips, then claims the right “rules of the road” can simultaneously constrain frontier labs and protect open-weights. Those two statements cannot both be true under the policies he actually advances.

@@BrianRoemmele796

Anthropic CEO Dario Amodei says the way for AI to win over the public is to 'actually' cure cancer

@u/socoolandawesome12000
Broadcast
Anthropic CEO warns that without guardrails, AI could be on dangerous path

Anthropic CEO warns that without guardrails, AI could be on dangerous path

Anthropic CEO speaks about 'powerful' AI risks and regulation

Anthropic CEO speaks about 'powerful' AI risks and regulation

Don't Freeze State AI Laws Without Federal Standards – Dario Amodei

Don't Freeze State AI Laws Without Federal Standards – Dario Amodei